Results 141 to 150 of about 351,379 (204)

Association of Socioeconomic Position, Prostate-specific Antigen, and Age with Observation in Low-risk Prostate Cancer Patients in Switzerland. [PDF]

Eur Urol Open Sci
Scherer TP, Menges D, Bieri U, Wildisen L, Staehelin K, Schmid FA, Kaufmann B, Eberli D, Rohrmann S, Poyet C.   +9 more
europepmc   +1 more source

Utility of prostate-specific antigen derivatives to minimize unnecessary magnetic resonance imaging in patients with prior negative prostate biopsy. [PDF]

Sci Rep
Lee S, Ryu H, Song SH, Hwang SI, Lee HJ, Lee H, Hong SK, Byun SS, Song B.   +8 more
europepmc   +1 more source

The predictive value of multiparametric magnetic resonance imaging in enhancing prostate-specific antigen assessment for prostate cancer: a cross-sectional study. [PDF]

Transl Androl Urol
Yu H, Wu J, Yang S.
europepmc   +1 more source

Prediagnosis Prostate-Specific Antigen Testing History in Patients With Incident Prostate Cancer.

JAMA Netw Open
Guittet L, Denis P, Tuppin P, Fiard G, Mathieu R, De Bels F, Le Bihan C, Rachas A.   +7 more
europepmc   +1 more source

Diagnostic value of prostate magnetic resonance imaging in men with prostate-specific antigen levels ≥ 15 ng/mL for biopsy decision-making. [PDF]

Insights Imaging
Trappe S, Schimmöller L, Althoff P, Schero KJ, Berg S, Radtke JP, Esposito I, Roghmann F, Albers P, Antoch G, Al-Monajjed R, Boschheidgen M.   +11 more
europepmc   +1 more source

Association between grain intake and prostate-specific antigen: A cross-sectional study from US men. [PDF]

Medicine (Baltimore)
Xie H, Xie H, Wang S, Liang Y, Zhao X, Liu H, Jiang B, Liu D, Xu Y, Zhang H.   +9 more
europepmc   +1 more source

Prostate specific antigen retesting intervals and trends in England: population based cohort study. [PDF]

BMJ
Collins KK, Oke JL, Virdee PS, Perera R, Nicholson BD.   +4 more
europepmc   +1 more source

Intermittent androgen deprivation therapy for biochemical recurrence or prostate-specific antigen (PSA) persistence after radical prostatectomy: efficacy and prognostic factors. [PDF]

Transl Androl Urol
Chen J, Chen Q, Yan X, Wang Z, Wang Y, Zhang Y, Zhang J, Xu J, Zhang J, Zhang D, Liu Q, Lan W, Jiang J.   +12 more
europepmc   +1 more source

Remarkable Response to Etoposide and Cisplatin in Aggressive-Variant Prostate Cancer With Low Prostate-Specific Antigen Levels: A Case Report. [PDF]

Cureus
Ikeda J, Taniguchi H, Inoue M, Masuo Y, Nakamoto T, Yanishi M, Uchida K, Kinoshita H.   +7 more
europepmc   +1 more source

Prognostic Role of Prostate-Specific Antigen (PSA) in male patients hospitalized for COVID-19. [PDF]

Pak J Med Sci
Ceylan Y, Demir I, Calik S, Akan OY, Yoldas E.   +4 more
europepmc   +1 more source